lexi
IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 587 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

LETTER TO THE EDITOR

Indian perspective of remdesivir: A promising COVID-19 drug

Singh Devendra, Wasan Himika, Mathur Apoorva, Gupta Yogendra Kumar

Year : 2020| Volume: 52| Issue : 3 | Page no: 227-228

   This article has been cited by
 
1 Pyrazole Bearing Pyrimidine Analogues as the Privileged Scaffolds in Antimicrobial Drug Discovery: A Review
Harsh D Trivedi, Vidhi B Joshi, Bonny Y Patel
Analytical Chemistry Letters. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database
Vaishali Gupte, Rashmi Hegde, Sandesh Sawant, Kabil Kalathingal, Sonali Jadhav, Rohit Malabade, Jaideep Gogtay
BMC Infectious Diseases. 2022; 22(1)
[Pubmed]  [Google Scholar] [DOI]
3 Spinal Muscular Atrophy Therapeutics in India: Parental Hopes and Despair!
Renu Suthar, Amol N Patil
Annals of Neurosciences. 2021; : 0972753121
[Pubmed]  [Google Scholar] [DOI]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow